Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
1 minute read

This 7% Yielding ETF Was Ravaged By Ukraine War. Is Now The Time To Buy?

By Robert Kuczmarski
September 24, 9:13 AM
The iShares MSCI Germany Index Fund is down roughly 39% year-to-date, after hitting a high of $33.51 back in January 2022. The steepest decline in the exchange traded fund took place shortly after Russia decided to mobilize its troops into Ukraine as a “specialty military operation,” which took place in February 2022.

EWG

Read More
3 minute read

US Stock Futures Down Ahead Of Powell, PMI Data; Crude Oil Falls Sharply

By Lisa Levin
September 23, 5:10 AM
Pre-open movers U.S. stock futures traded lower in early pre-market trade on Friday after recording losses on Thursday. The Dow Jones closed lower by more than 100 points, while the Nasdaq Composite fell around 150 points in the previous session after the US Federal Reserve, on Wednesday, raised its policy rate by 75 basis points for the third time.

AIR

Read More
1 minute read

AstraZeneca Announced Ultomiris Approved in Europe for the Treatment of Adults with Generalized Myasthenia Gravis

By Charles Gross
September 23, 5:04 AM
Ultomiris (ravulizumab) has been approved in Europe as an add-on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody-positive. This decision marks the first and only approval for a long-acting C5 complement inhibitor for

AZN